Description

Acebrophylline

Drug class – Bronchodilator

• Significantly reduces airway inflammation and obstruction in chronic stages.

• A better choice than Theophylline for COPD patients having cardiovascular comorbidity.

• Significantly improves cough scoring and sputum quantity in patients with mild persistent asthma.

N-Acetylcysteine

Drug class – Mucolytic agent

• Facilitates the removal of pulmonary secretions & reduces the viscosity of sputum in both cystic fibrosis and COPD.

• Effectively prevents the Steroid resistant acute exacerbation of Asthma.

• Offers preventive effects against airways hyper-responsiveness.